Nocturnal sleep and daytime sleepiness in normal subjects with HLA-DQB1*0602
- PMID: 10341385
Nocturnal sleep and daytime sleepiness in normal subjects with HLA-DQB1*0602
Abstract
Narcolepsy, a neurological disorder characterized by excessive daytime sleepiness and abnormal REM sleep, is known to be tightly associated with the Human Leukocyte Antigen (HLA) DQ allele DQB1*0602. In this study, we have explored the possibility that normal subjects carrying this HLA allele (25% of the general population) could display subclinical REM sleep abnormalities and increased daytime sleepiness. Data from 525 middle-aged adults enrolled in the Wisconsin Sleep Cohort study were used for this analysis. Nocturnal polysomnography, sleep latency during the multiple sleep latency test (MSLT), and questionnaire items pertaining to excessive daytime sleepiness were compared between DQB1*0602 positive (n = 132) and negative (n = 393) participants. Results indicate shorter REM latency whether or not the latency was adjusted for wake after sleep onset (p = 0.003) and p = 0.02 respectively), increased sleep efficiency (p = 0.06) and decreased percent time spent in stage I sleep (p = 0.02) during nocturnal polysomnography in DQB1*0602 subjects. Data gathered using the Multiple Sleep Latency Test or the Epworth and Stanford sleepiness scales did not differentiate between DQB1*0602 positive and negative subjects. These results support the hypothesis that polymorphisms at the level of HLA DQ modulates sleep tendencies in humans.
Similar articles
-
Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.Brain. 2006 Jun;129(Pt 6):1609-23. doi: 10.1093/brain/awl079. Epub 2006 Apr 5. Brain. 2006. PMID: 16597649
-
The clinical spectrum of narcolepsy with cataplexy: a reappraisal.J Sleep Res. 2004 Dec;13(4):395-406. doi: 10.1111/j.1365-2869.2004.00422.x. J Sleep Res. 2004. PMID: 15560774
-
Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.Sleep Med. 2009 Dec;10(10):1146-50. doi: 10.1016/j.sleep.2009.03.008. Epub 2009 May 21. Sleep Med. 2009. PMID: 19464232
-
[Wake disorders. I. Primary wake disorders].Rev Neurol (Paris). 1998 Feb;154(2):111-29. Rev Neurol (Paris). 1998. PMID: 9773032 Review. French.
-
Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.Sleep Med Rev. 2005 Aug;9(4):269-310. doi: 10.1016/j.smrv.2005.03.004. Sleep Med Rev. 2005. PMID: 16006155 Review.
Cited by
-
HLA-DQB1*06:02 allele frequency and clinic-polysomnographic features in Saudi Arabian patients with narcolepsy.Sleep Breath. 2019 Mar;23(1):303-309. doi: 10.1007/s11325-018-1717-4. Epub 2018 Sep 5. Sleep Breath. 2019. PMID: 30187366
-
Genetic Markers of Differential Vulnerability to Sleep Loss in Adults.Genes (Basel). 2021 Aug 26;12(9):1317. doi: 10.3390/genes12091317. Genes (Basel). 2021. PMID: 34573301 Free PMC article. Review.
-
Nocturnal REM Sleep Without Atonia Is a Diagnostic Biomarker of Pediatric Narcolepsy.J Clin Sleep Med. 2018 Feb 15;14(2):245-252. doi: 10.5664/jcsm.6944. J Clin Sleep Med. 2018. PMID: 29351827 Free PMC article.
-
Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?Sleep. 2010 Jan;33(1):29-35. doi: 10.1093/sleep/33.1.29. Sleep. 2010. PMID: 20120618 Free PMC article.
-
Circadian gene variants influence sleep and the sleep electroencephalogram in humans.Chronobiol Int. 2016;33(5):561-73. doi: 10.3109/07420528.2016.1167078. Epub 2016 Apr 18. Chronobiol Int. 2016. PMID: 27089043 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials